Latest News

Smaregi (TSE:4431) has put up another busy quarter, with Q3 2026 revenue at roughly ¥3.4b and basic EPS of ¥33.38, set against trailing twelve month revenue of ¥12.8b and EPS of ¥100.28 that reflect a 22.8% earnings increase over the past year. The company has seen revenue climb from ¥8.4b to ¥12.8b and trailing EPS move from ¥63.21 to ¥100.28 over the past two years, which gives a clearer sense of how the latest quarter sits within a steadily expanding top and bottom line. With a 15.1% net...

Leadership change in focus for Springer Nature KGaA Springer Nature KGaA (XTRA:SPG) has appointed Anna Troise as President, North America, a new leadership role focused on the U.S. research business and the group’s broader academic relationships in the region. See our latest analysis for Springer Nature KGaA. The leadership news lands at a time when Springer Nature KGaA’s €15.32 share price has a 1-day share price return of 2.68%, a 30-day share price return of 6.36%, and a year-to-date share...

What Greenbrier’s recent performance tells you Greenbrier Companies (GBX) has drawn fresh attention after a mixed stretch in its share performance, with a roughly 6% decline over the past month alongside a gain of about 10% in the past 3 months. For investors tracking railcar manufacturing and leasing, the stock’s recent pullback compared with its longer multi year total returns raises questions about how to interpret Greenbrier’s current valuation and earnings profile. See our latest...

gumi (TSE:3903) has laid out a mixed Q3 2026 scorecard, with revenue of ¥2.98 billion and net income of ¥496 million translating into basic EPS of ¥9.58, set against a trailing 12 month basic EPS of ¥48.03 and net income of ¥2.40 billion that still reflects the impact of a large one off gain. The company has seen revenue move across recent quarters from ¥2.65 billion in Q2 2025 to ¥1.91 billion in Q3 2025, ¥1.54 billion in Q4 2025, then to ¥1.35 billion in Q1 2026, ¥2.50 billion in Q2 2026...

Fastly (FSLY) shares have climbed sharply after a strong fourth quarter, upbeat commentary on AI driven traffic, and sector wide enthusiasm following Nvidia’s multi billion dollar investment in peer cloud provider Nebius. See our latest analysis for Fastly. At a share price of $24.58, Fastly’s recent 30 day share price return of 164.02% and year to date share price return of 141.22% point to strong momentum. The 1 year total shareholder return of 258.83% contrasts with a 5 year total...

United Therapeutics (NasdaqGS:UTHR) published full phase 3 TETON-2 results for Tyvaso in idiopathic pulmonary fibrosis (IPF) in the New England Journal of Medicine. The study reported that inhaled Tyvaso preserved lung function and reduced clinical worsening in IPF patients. The company plans to seek FDA approval to add IPF as a new indication on the Tyvaso label. For you as an investor, this centers on United Therapeutics' core focus on pulmonary diseases, where Tyvaso is already an...

Earlier this week, TE Connectivity plc’s board approved a 10% hike in its regular quarterly cash dividend to US$0.78 per ordinary share from US$0.71, payable on June 12, 2026, to shareholders of record as of May 22, 2026, and also lifted its share repurchase authorization by US$3.00 billion to a total of US$22.25 billion. Together, the higher cash dividend and expanded buyback program highlight TE Connectivity’s emphasis on returning capital to shareholders alongside its role as a major...

ACM Research (ACMR) recently reported record 2025 revenue and reaffirmed its 2026 outlook, highlighting demand for its cleaning tools and new orders across Singapore, North America, and Southeast Asia. See our latest analysis for ACM Research. The 2.45% 1 day share price return to US$46.38 sits alongside a 3.25% 7 day gain but follows a 34.38% 30 day share price decline. Total shareholder returns of 58.94% over 1 year and roughly 3x over 3 years point to longer term momentum that has stayed...

Morozoff (TSE:2217) has wrapped up FY 2026 with fourth quarter revenue of ¥14.0b and basic EPS of ¥42.02, following earlier quarters that ranged from a loss per share of ¥23.39 in Q3 to a marginally positive ¥0.35 in Q2. Over the past year, the company has seen trailing twelve month revenue move around the ¥36.3b mark with basic EPS shifting from ¥87.19 to ¥31.81, while net income across individual quarters has swung between a loss of ¥473m and a profit of ¥1.07b. This leaves investors to...

GE Vernova (NYSE:GEV) has been selected to supply turbines for the Fortore wind farm project in Italy, a substantial new win in the European onshore wind market. The company has also signed a memorandum of understanding with Hitachi to jointly pursue deployment of BWRX-300 small modular reactors across Southeast Asia. These two announcements expand GE Vernova's role in both renewables and nuclear power at a time when low carbon generation is a priority for many regions. For investors...

James Hardie Industries (ASX:JHX) executives are facing an investigation into potential breaches of fiduciary duties linked to disclosures about the North America Fiber Cement segment. The probe and related lawsuit allege that certain directors and officers misled investors by denying ongoing inventory destocking in this key business unit. The case focuses on whether company leaders accurately represented segment performance and inventory trends to the market. James Hardie is a major player...

Nareru Group (TSE:9163) opened FY2026 with Q1 revenue of ¥6.3 billion and basic EPS of ¥56.80, alongside net income excluding extra items of ¥497 million. Over the past few quarters the company has seen revenue move from ¥5.8 billion in Q4 2024 to ¥5.9 billion in Q1 2025 and up to ¥6.3 billion in Q1 2026. Basic EPS shifted from ¥80.34 to ¥74.50 and then to ¥56.80, setting up a results season in which investors will be weighing margin pressure against the longer term earnings profile and what...

Event driven rethink of CONMED (CNMD) Recent commentary that CONMED (CNMD) could see a 1.3% revenue decline over the next year, after sales growth already lagged the broader healthcare sector, has sharpened investor focus on the company's demand outlook. See our latest analysis for CONMED. At a share price of US$37.28, CONMED has seen pressure build over time, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 36.16% loss. This points to fading...

Several recent developments around Expand Energy (EXE), including a 24% year over year organic reserve increase, upbeat 2025 results and outlook, insider share purchases, and a reaffirmed dividend, have brought the stock back into focus for investors. See our latest analysis for Expand Energy. At a share price of $107.02, Expand Energy has seen a 3.47% 30 day share price return and a 7.56% 1 year total shareholder return. This suggests momentum that has recently cooled after analyst upgrades,...

This article considers whether AstraZeneca shares offer fair value at current levels or whether the current price already reflects most of the good news, and walks through that question in plain terms. AstraZeneca's share price closed at £143.80, with a 7 day return of 0.8% decline, a 30 day return of 3.0% decline, and longer term returns of 5.8% year to date, 22.0% over 1 year, 41.2% over 3 years and 124.7% over 5 years. Recent trading has been influenced by ongoing attention on big pharma...

Ohara (TSE:5218) opened Q1 2026 with revenue of ¥7,175 million and basic EPS of ¥14.05, setting a fresh reference point against a share price of ¥1,111. Over the past year, the company has seen quarterly revenue range from ¥6,873 million to ¥7,828 million, while basic EPS moved between ¥12.52 and ¥24.63. On a trailing twelve month basis, EPS sits at ¥72.59 on revenue of ¥29,197 million. With net profit margins around 6% and a recent one off gain influencing the trailing numbers, this set of...

Dividend increase and full year results put income focus on CITIC Telecom CITIC Telecom International Holdings (SEHK:1883) has drawn fresh attention after releasing its 2025 results, pairing steady earnings with a slightly higher dividend that may interest income focused investors. See our latest analysis for CITIC Telecom International Holdings. The latest full year earnings and dividend announcement have come alongside a 1 month share price return of 4.23% and an 8.84% year to date share...

In March 2026, Tradeweb Markets Inc. reported February trading volume of US$61.80 trillion and average daily volume of US$3.10 trillion, marking very large year-over-year growth in activity. These figures, alongside recent commentary highlighting Tradeweb’s expanding electronic trading footprint and multi-asset platform strength, reinforce how central its marketplaces have become to fixed income price discovery and liquidity. Now we’ll explore how this surge in electronic trading volumes may...

Why Caesars Entertainment (CZR) is on investors’ radar Caesars Entertainment (CZR) has caught investor attention after a strong month for the stock, prompting a closer look at how its current share price lines up with recent business performance. See our latest analysis for Caesars Entertainment. At a share price of US$28.06, Caesars has posted a 41.43% 1 month share price return and 19.10% year to date share price return, yet the 1 year total shareholder return is roughly flat and the 5 year...

Packaging Corporation of America (PKG) recently reported Q4 results with revenue up 10.1% year over year, while both revenue and adjusted operating income came in below analyst expectations, drawing attention to execution and integration progress. See our latest analysis for Packaging Corporation of America. The latest Q4 miss has come after a strong stretch for shareholders, with a 1-year total shareholder return of 11.67% and a 3-year total shareholder return of 82.73%. At the same time,...

If you are wondering whether Nexa Resources at around US$10.95 is still offering value after its recent run, you are not alone. This article will focus on what the current price might imply. The stock has returned 0.7% over the last 7 days and 24.6% year to date, with a 112.9% return over the past year, even though the 30 day return sits at an 11.6% decline. Recent news flow around Nexa Resources has centered on broader sector sentiment, funding conditions and company-specific operational...

Why LCI Industries Is On Investor Radars Today LCI Industries (LCII) has attracted fresh attention after a period of mixed share performance, including a return of about 43% over the past year and negative moves in the past month. See our latest analysis for LCI Industries. LCI Industries’ share price has eased back recently, with a 30 day share price return showing a decline of 21.23% and a 7 day decline of 4.89%, even though the 1 year total shareholder return is 43.46%, which points to...

If you are wondering whether Catalyst Pharmaceuticals' current share price still offers value, you are not alone. The stock has attracted attention from investors trying to work out if it is priced fairly. The share price closed at US$23.23 recently, with returns of a 4.2% decline over 7 days, a 2.9% decline over 30 days, a 0.3% gain year to date, 10.5% over 1 year, 45.9% over 3 years and a very large gain over 5 years. Recent coverage has focused on the company as part of wider discussions...

Sabine Royalty Trust (SBR) drew fresh attention after reporting March 2026 production results along with a new cash distribution, giving income focused investors updated data on both operating activity and near term payout levels. See our latest analysis for Sabine Royalty Trust. Those March production figures and the fresh cash distribution land at a time when momentum in Sabine Royalty Trust’s unit price has been building. The 30 day share price return is 5.70%, the year to date share price...